Latest Insider Transactions at Galera Therapeutics, Inc. (GRTX)
This section provides a real-time view of insider transactions for Galera Therapeutics, Inc. (GRTX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Galera Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Galera Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 12
2019
|
Novo Holdings > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
500,000
+12.79%
|
$6,000,000
$12.0 P/Share
|
|
Nov 12
2019
|
Novo Holdings > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
2,909,021
+32.78%
|
-
|
|
Nov 12
2019
|
Blackstone Clarus Gp L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
250,000
+12.96%
|
$3,000,000
$12.0 P/Share
|
|
Nov 12
2019
|
Blackstone Clarus Gp L.P. > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
1,428,984
+50.0%
|
-
|
|
Nov 12
2019
|
Novartis Bioventures LTD |
BUY
Open market or private purchase
|
Indirect |
250,000
+6.59%
|
$3,000,000
$12.0 P/Share
|
|
Nov 12
2019
|
Novartis Bioventures LTD |
BUY
Conversion of derivative security
|
Indirect |
3,293,067
+50.0%
|
-
|